Paion AG Stock
The Paion AG price is unchanged compared to yesterday.
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Paion AG stock is not clear.
As a result the target price of €2.00 shows a very positive potential of 90.476% compared to the current price of €1.05 for Paion AG.
For the coming years our community has positive and negative things to say abot the Paion AG stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Paion AG in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Paion AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Paion AG | 0.000% | 10.643% | 17.581% | -44.030% | -13.079% | -53.333% | -62.540% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1.710% | -1.681% | -10.000% | -32.823% | -22.687% | -13.333% | -62.154% |
| MagForce AG | -1.320% | -13.308% | -93.133% | -97.143% | -95.809% | -97.424% | -98.336% |
| Affimed N.V. | -1.210% | 1.257% | 13.218% | -36.876% | -32.933% | 28.484% | - |
Comments
News
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY
DGAP-News: PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN ADULTS IN GERMANY
DGAP-News: PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE
DGAP-News: PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE
DGAP-News: PAION AG: ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS AND ELECTS MICHAEL SCHLENK AND GREGOR SIEBERT TO THE SUPERVISORY BOARD
DGAP-News: PAION AG: ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS AND ELECTS MICHAEL SCHLENK AND GREGOR SIEBERT TO THE SUPERVISORY BOARD